scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1051492443 |
P356 | DOI | 10.1007/S10620-010-1402-3 |
P698 | PubMed publication ID | 20848202 |
P50 | author | Andreas G. Tzakis | Q64162946 |
P2093 | author name string | David Levi | |
Paul Martin | |||
Pablo A Bejarano | |||
Jang Moon | |||
Kishore Maganty | |||
Leopoldo Arosemena | |||
P2860 | cites work | Liver transplantation for combined hepatocellular cholangiocarcinoma | Q80256706 |
Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma | Q80337206 | ||
Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma | Q83355604 | ||
Management of hepatocellular carcinoma | Q29616230 | ||
Intrahepatic cholangiocarcinoma presenting as the Budd-Chiari syndrome: a case report and literature review | Q36338102 | ||
Management of combined hepatocellular and cholangiocarcinoma. | Q37088469 | ||
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study | Q38381235 | ||
Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma | Q38497061 | ||
Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation. | Q40742371 | ||
Combined liver cell and bile duct carcinoma. | Q41980432 | ||
Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period | Q42635593 | ||
A clinicopathological study on combined hepatocellular and cholangiocarcinoma | Q43657340 | ||
Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. | Q45279934 | ||
Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings | Q46402456 | ||
Hepatic artery thrombosis after adult liver transplantation. | Q52951233 | ||
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. | Q53366237 | ||
Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging. | Q53479218 | ||
Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment | Q68450860 | ||
Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features | Q71710116 | ||
Combined hepatocellular carcinoma and cholangiocarcinoma: Clinical features and computed tomographic findings | Q72102297 | ||
Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features | Q73044883 | ||
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases | Q73797012 | ||
Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study | Q74593923 | ||
Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors | Q77879718 | ||
Cholangiocarcinoma presenting with recurrent venous thrombosis | Q79338076 | ||
Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population | Q79397825 | ||
Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma | Q79914640 | ||
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma | Q79996094 | ||
P433 | issue | 12 | |
P921 | main subject | cholangiocarcinoma | Q124292 |
hepatocellular carcinoma | Q1148337 | ||
liver transplantation | Q1368191 | ||
intrahepatic cholangiocarcinoma | Q18556554 | ||
P304 | page(s) | 3597-3601 | |
P577 | publication date | 2010-09-17 | |
P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
P1476 | title | Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation | |
P478 | volume | 55 |
Q40621862 | Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy. |
Q60928177 | Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions |
Q57150951 | Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor |
Q38445643 | Comparison between resection and transplantation in combined hepatocellular and cholangiocarcinoma. |
Q34135201 | Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine |
Q42262646 | Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C. |
Q40914145 | Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A case report |
Q38998297 | Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review |
Q35903794 | Liver cancer: Approaching a personalized care |
Q38821374 | Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun |
Q37360183 | Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital |
Q44808185 | Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma |
Q90736364 | Treatment of Combined Hepatocellular and Cholangiocarcinoma |
Search more.